Introduction
Uracil can arise in DNA by hydrolytic deamination of cytosine, generating a premutagenic U : G mispair. Uracil may also occur in a U : A base pair, through occasional use of dUTP instead of TTP during DNA replication. Multiple uracil-DNA glycosylase enzymes are widely distributed in bacteria, archaea, and eukaryotes (Aravind and Koonin, 2000) , signifying the importance of eliminating uracil from the genome. We have previously reported the generation of gene-targeted mice deficient in the ubiquitous Ung uracil-DNA glycosylase (Nilsen et al., 2000) . The modest increase (o1.5-fold) in spontaneous mutation frequency in Ung À/ À mice (Nilsen et al., 2000) was consistent with the presence of a second major uracil-DNA glycosylase activity able to repair deaminated cytosine, contributed by the Smug1 enzyme (Haushalter et al., 1999; Nilsen et al., 2001) . A primary role for Ung during DNA replication was revealed in Ung À/À mice, where slow removal of misincorporated uracil residues resulted in a B100-fold increased steady-state level of uracil in DNA (Nilsen et al., 2000) . This is consistent with the direct interaction of mammalian UNG with PCNA and RPA in the replisome (Otterlei et al., 1999) .
Replicative DNA polymerases discriminate poorly between TTP and dUTP, an intermediate in the de novo biosynthesis pathway for TTP, and thus dUMP will be incorporated into newly synthesized DNA in proportion to the size of the dUTP pool (Goulian et al., 1980) . The resulting U : A base pair is neither cytotoxic nor mutagenic, but substitution of thymine for uracil in DNA might have deleterious effects, such as changing the affinity of a DNA-binding factor for its target sequence (Verri et al., 1990) , which could conceivably compromise cellular function. The combined action of dUTPase, in maintaining a small dUTP pool, and uracil-DNA glycosylase(s), normally ensures a very low steady-state level of dUMP residues in the genome. Folate deficiency, as well as cytotoxicity of antifolate cancer chemotherapeutic drugs such as 5 0 -fluorouracil and methotrexate, have been proposed to act through elevation of the dUTP pool, an increased dUMP content in DNA and the generation of DNA strand breaks via futile UNG-initiated insertion/repair cycles (Goulian et al., 1980; Blount et al., 1997) .
The regulated introduction of uracil into DNA may actually be employed as a means of targeting mutations. Thus, the DNA deamination model of antibody diversification postulates that uracil introduced by enzymatic deamination of cytosine by AID (activation induced deaminase) could function as an initiating DNA base lesion for both somatic hypermutation and class switch recombination of immunoglobulin genes. This model has gained substantial support (Di Noia and Neuberger, 2002; Martin and Scharff, 2002; PetersenMahrt et al., 2002) and the Ung enzyme was shown to be the major uracil-DNA glycosylase responsible for processing the initiating U : G lesions in the mouse (Rada et al., 2002) . Thus, although the lack of a generalized mutator phenotype in Ung-deficient mice is consistent with Ung acting on U : A base pairs arising during DNA replication, with Smug1 accounting for correction of U : G lesions resulting from spontaneous deamination of cytosine in the genome as a whole, Ung apparently has a specific role processing U : G lesions targeted to immunoglobulin variable (V) genes.
We have previously reported that, despite an increased steady-state level of uracil in their genome, Ung À/À null mice apparently developed normally, with no overt phenotype or marked pathological changes, and remained tumour-free at 1 year of age (Nilsen et al., 2000) . However, as cancer is largely a disease of old age, and in the light of the defect in antibody diversification, we have now analysed ageing Ung-deficient mice.
Results
Increased morbidity, hyperplasia of lymphoid organs and lymphomas in Ung-deficient mice Figure 2a ) in 34% of Ung À/À mice, with systemic involvement of spleen plus lymph nodes (the latter also often grossly enlarged; Figure 2b ) in 28%. This was significantly elevated compared to Ung þ / þ controls, where the spleen was enlarged (usually only 2-3 Â ) in 16% of mice, with systemic involvement of lymph nodes in 1.3% (the latter reflecting a single individual). Unusually, the thymus remained prominent, and was even enlarged in 22% of older Ung À/À mice, compared to 3.9% of controls. Furthermore, enlargement of the thymus in Ung À/À mice occurred almost exclusively when spleen and lymph nodes were also Statistical evaluation was performed from 2 Â 2 contingency tables using established methods; probability (P) values were calculated using the w 2 test at the 95% significance level. (a) Spleen (B20 Â enlarged) from an Ung À/À male that died at 15 months of age. (b) Mesenteric lymph node from the same animal; all lymph nodes were grossly enlarged. Normal spleen and mesenteric lymph node from an age-matched male control, and scale-bars (1 cm), are included for comparison B-cell lymphomas in Ung null mice H Nilsen et al affected; this was not the case in control animals. There was no increase in the incidence of solid tumours in nonlymphoid organs of Ung À/À vs Ung þ / þ mice. However, most strikingly, there were palpable solid tumours of the spleen, and also the mesentery lymph nodes, in 12% of Ung À/À mice; no splenic tumours were seen in Ung þ / þ controls. The observed hyperplasia of multiple lymphoid organs in 28% of Ung À/À mice indicated abnormal lymphoproliferation that later manifested as lymphomas in approximately half of these animals.
Lymphoma may be indicated by the involvement of multiple lymphoid organs but can only be confirmed, or may be present without clear macroscopic changes and only become apparent, upon microscopic histopathological analyses (see below). Due to the large number of animals involved, it was not feasible to carry out systematic histopathology of lymphoid organs in all mice, so the incidence of lymphoma may be underestimated. However, even at the macroscopic level, as judged by splenic tumours, the relative incidence was greatly (410-fold) increased in Ung À/À mice.
Histopathology and immunohistochemistry of preneoplastic lymphoproliferation and lymphomas in Ung-deficient mice
Systematic histopathological analyses of 10 Ung À/À mice that died aged B2 years were carried out. At dissection, five animals had shown the typical macroscopic phenotype of enlarged spleen and lymph nodes (Figure 2 ), and this was confirmed as lymphoma upon microscopic analysis, with involvement of multiple organs and tissues (Figure 3) . In all cases, this was classified as intermediate-to high-grade (grades 2-3) follicular lymphoma ( Figure 3b and c) ; normal spleen is shown for comparison (Figure 3a) . Of the remaining five, atypical, mice, one had a lung tumour (confirmed as a primary adenocarcinoma) with no macroscopic enlargement of lymphoid organs, two had shown enlargement of (submandibular) lymph nodes alone, and two had exhibited no overt signs of disease or clear cause of death. However, all five mice, with only minor changes at dissection, displayed varying degrees of lymphoproliferation in several lymphoid organs and extranodal sites upon microscopic analysis. This consisted, in four cases, of neoplastic centroblastic/centrocytic lymphoid cells with the typical nuclear morphology and cytoarchitecture of low-grade follicular lymphoma (Figure 3d ), and the spleen and lymph nodes were involved. The salivary glands and salivary lymph nodes were invariably affected, with perivascular and periductal accumulation of lymphoid cells (Figure 3e ). Analysis of a further two, apparently healthy, Ung À/À mice killed at 12 months, revealed early B-cell lymphoproliferation in salivary glands and cervical/thoracic lymph nodes (Figure 3f ). Such early signs of lymphoproliferation were not observed in age-matched controls. Moreover, splenocytes from B3-month old Ung À/À mice showed increased proliferation (two-to threefold) in vitro in the absence of exogenous mitogens (data not shown).
At dissection, macroscopic inspection had identified hyperplasia of lymphoid organs as characteristic of the Ung À/À phenotype, with systemic involvement of spleen and lymph nodes in 28% of Ung À/À mice. Hyperplasia of both spleen and lymph nodes would be consistent with a diagnosis of lymphoma and indeed, approximately half of these animals (12% of Ung À/À mice) had macroscopic splenic tumours. Histopathology confirmed lymphoma in mice showing macroscopic hyperplasia of spleen and lymph nodes, so that the 28% of mice affected, compared to only 1.3% of controls (Table 1) , is a more accurate figure for the incidence of lymphoma. This represents a B22-fold increased incidence of lymphoma in Ung À/À mice. This figure remains a conservative estimate, given the occurrence of lymphoma in mice displaying no macroscopic changes in the spleen. Immunohistochemical staining of normal (Figure 4a ) vs Ung À/À spleen demonstrated that proliferating cells, low-and high-grade lymphoma were all of B-cell origin, expressing the pan B-cell CD45R antigen (Figure 4b and c). Immunostaining for CD3 showed the presence of some, presumably tumour-reactive, T cells but there was 
Discussion
We report that mice deficient in the Ung uracil-DNA glycosylase show increased morbidity beyond 1 year of age compared to normal controls and a more than 20-fold increased incidence of B-cell lymphomas. Preneoplastic lymphoproliferation, together with lymphoid infiltration in a number of organs, are seen in the spleen of younger Ung À/À mice with no overt malignant changes. These data describe the development of spontaneous malignancies due to deficiency in a DNA glycosylase and suggest that the high incidence of B-cell lymphomas observed in older Ung-deficient mice is a late manifestation of an underlying lymphoproliferative disorder.
The DNA base excision repair pathway is the major mode of repair for spontaneous base lesions and therefore an important antimutagenic defence strategy (Lindahl, 2000) . To date, however, DNA glycosylasedeficient knockout mouse models have not been associated with a cancer-prone phenotype (Scha¨rer and Jiricny, 2001 ). Thus, gene-targeted mice deficient in either the Mpg 3-methyladenine-DNA glycosylase (Engelward et al., 1997; Elder et al., 1998) or the Nth1 thymine glycol-DNA glycosylase (Elder and Dianov, 2002; Ocampo et al., 2002; Takao et al., 2002) do not have an increased spontaneous cancer frequency. Mice deficient in the Mbd4 DNA glycosylase, which excises deaminated 5-methylcytosine residues, clearly exhibit increased tumorigenesis, but only when assayed in a cancer-susceptible Apc Min/ þ background, with enhanced levels of CpG to TpG mutations in the target Apc gene (Millar et al., 2002; Wong et al., 2002) . As a consequence, the Mbd4 À/À knockout mice show reduced survival on the Apc Min/ þ background. Gene-targeted mice deficient in the Ogg1 8-hydroxyguanine-DNA glycosylase did not exhibit an increased cancer frequency in two separate studies (Klungland et al., 1999; Minowa et al., 2000) ; a third group has reported apparent Ogg1 knockout-associated lung tumorigenesis, but this was dependent on a second gene locus (Sakumi et al., 2003) . Here, the spontaneous development of Bcell lymphomas in Ung À/À mice was found in animals with no other known mutation predisposing these mice to malignancy. Recently, a nonsense mutation has been identified in DNA polymerase iota from 129-derived strains of mice (McDonald et al., 2003) . In the present study, at least two-thirds of Ung À/À mice that developed B-cell lymphomas were DNA polymerase iota-proficient (data not shown).
Inherited defects in the MYH DNA glycosylase, which excises A misincorporated opposite 8-hydroxyguanine, have recently been shown to be associated with an increased level of somatic mutations in human colorectal tumours (Al-Tasaan et al., 2002; Sieber et al., 2003) . No mutations of the human UNG gene have been reported in tumour cell lines (Kvaly et al., 2001) . The lymphoid malignancies in Ung À/À null mice are unlikely to result from genome-wide mutagenesis due to the uracil-DNA glycosylase deficiency, since there is only a very modest increase in spontaneous mutation frequency in both the spleen and thymus of Ung À/À null mice, at least of a nontranscribed lacI transgene (Nilsen et al., 2000) . However, we cannot exclude the possibility of transcription-associated mutagenesis at uracil residues (Wright et al., 2002) , leading to local accumulation of mutations. There is no cytogenetic evidence for increased general genome instability in an Ung-deficient vs control mouse embryo fibroblast cell line (Nilsen et al., 2000) , and levels of sister chromatid exchanges were within the normal range in Ung À/À cells (data not shown). It seems likely that a second major uracil DNA glycosylase in mammalian cells, Smug1, serves as the antimutator at rare U : G lesions caused by general hydrolytic deamination of cytosine, with Ung acting primarily on U : A base pairs at the replication fork .
Recent developments have shown that Ung also has a specific role in the immune system at U : G base pairs, processing such lesions generated in immunoglobulin V genes by enzymatic deamination of cytosine (Rada et al., 2002) . In this context, normal efficient and faithful baseexcision repair (Lindahl, 2000) is circumvented, and the pattern of antibody diversification depends on the mode of resolution of the U : G lesion. Excision of the uracil residue produces an abasic site that upon translesion synthesis generates mutations according to the insertion preference of the DNA polymerase involved, whereas replication over the U : G lesion generates C to T transitions. In Ung À/À mice, there is a dramatic skewing of the pattern of hypermutation towards C to T transitions, demonstrating that Ung is the major uracil-DNA glycosylase responsible for processing the programmed U : G lesions. Class switch recombination is severely inhibited in Ung À/À mice, indicating that the major pathway largely proceeds via formation of an abasic site by the Ung enzyme at the programmed U : G base pairs (Rada et al., 2002) . In a separate study, inducible somatic hypermutation in a human lymphoma cell line was apparently dependent on the error-prone DNA polymerase iota (Faili et al., 2002) . It should be noted that we have genotyped the Ung À/À mice compromised in somatic hypermutation as DNA polymerase iota-proficient (Rada et al., 2002; H Nilsen and R Woodgate, unpublished data) .
The implication of these findings would be that Ung deficiency interferes directly with B-cell differentiation in Ung À/À mice, with the malignant phenotype observed here being a late consequence of perturbed processing of antibody genes. B-cell lymphomas are commonly associated with chromosomal translocations that often deregulate oncogene expression, and although the precise mechanisms are unknown, have been proposed to result from aberrant hypermutation and isotype switching in germinal centre B cells (Ku¨ppers and DallaFavera, 2001 ). Somatic hypermutation has been shown to target multiple non-immunoglobulin loci, including proto-oncogenes, in a subset of germinal centre-derived lymphomas. This indicates a malfunction of somatic hypermutation in these diffuse large-cell lymphomas and, as the hypermutable loci were also susceptible to chromosomal translocations, a role for hypermutation in generating translocations via DNA double-strand breaks (Pasqualucci et al., 2001) . Paradoxically, class switch recombination, and therefore presumably DNA double-strand break formation, is inhibited in Ung À/À mice, arguing against chromosomal translocation as the major mode of lymphomagenesis in these mice. However, if somatic hypermutation were to target nonimmunoglobulin genes, then the skewed pattern of hypermutation in Ung-deficient mice would result in transition mutations of C : G base pairs at multiple loci. Indeed, the spectrum of V gene mutations in a subset of human B-cell lymphomas appears to be biased towards transitions at C : G base pairs (Stevenson et al., 2001) . Long-term studies will seek to establish Ung-deficient Bcell lines and tumour explants in order to analyse the molecular mechanisms underlying lymphomagenesis in Ung-deficient mice. It would also seem pertinent to search for mutations of the human UNG gene in follicular and diffuse large B-cell lymphomas.
Somatic hypermutation and class switch recombination are both abrogated in Aid À/À mice . It should be noted that Ung À/À mice differ from Aid À/À mice in being able to carry out somatic hypermutation of V genes, albeit with altered specificity, and having a residual level of class switch recombination (Rada et al., 2002) , although IgM accumulates in the serum of both Aid À/À and Ung À/À mice. AID-deficiency causes a form of human hyper-IgM syndrome (Revy et al., 2000) ; the AID-deficient disease phenotype in mice and man is associated with germinal centre hyperplasia in lymphoid organs, but not malignant lymphoma or infiltration of extranodal sites as seen here in Ung-deficient mice. Given that premutagenic lesions would be formed but aberrantly processed in Ung À/À mice, a more severe phenotype, as seen here, would be expected for Ung-vs AID-deficiency. Furthermore, it can be predicted from the DNA deamination model that Ung À/À mice would not develop B-cell lymphomas in an AID-deficient background. How AID, and UNG, are targeted to V genes remains unclear, although transcription is required for AID-induced somatic hypermutation of immunoglobulin genes and nonphysiological targets (Peters and Storb, 1996) . Finally, experimental Ung À/À mice have been maintained under specific pathogen-free conditions but in nature these animals may be susceptible to bacterial infections due to their deficiency in switching heavy chain classes. Such a role for the Ung uracil-DNA glycosylase in immunocompetence, and thus organism fitness and lifespan, might explain the extraordinary conservation of the UNG coding sequence through evolution and the apparent lack of genetic polymorphisms in the human population (Kvaly et al., 2001 ).
Materials and methods

Mice breeding
Gene-targeted Ung À/À null mice have been described (Nilsen et al., 2000) . Ung À/À and Ung þ / þ populations were bred from the homozygous progeny of F1 heterozygotes and maintained under specific pathogen-free conditions. Age at death was recorded and systematic macroscopic post-mortem analyses of all mice were carried out.
Histopathology
Dissected tissues were fixed in 10% formalin, embedded in paraffin, and the sections were stained with haematoxylin and eosin. Immunohistochemistry was performed using mouse antibodies specific for the B-cell marker CD45R and the pan T-cell marker CD3 (Pharmingen), followed by anti-mouse IgG coupled to streptavidin-biotin complex, and detected by incubation with diaminobenzidine.
